Report Thumbnail
Product Code LP0914511471UB9
Published Date 2023/3/20
English104 PagesGlobal

Global Genomics Market Growth (Status and Outlook) 2023-2029Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP0914511471UB9◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/3/20
English 104 PagesGlobal

Global Genomics Market Growth (Status and Outlook) 2023-2029Pharmaceutical_LifeSciense Market



Abstract


Summary

The global Genomics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Genomics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Genomics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Genomics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Genomics players cover 10X Genomics Inc., Abcam Plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Genomics Industry Forecast” looks at past sales and reviews total world Genomics sales in 2022, providing a comprehensive analysis by region and market sector of projected Genomics sales for 2023 through 2029. With Genomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genomics industry.
This Insight Report provides a comprehensive analysis of the global Genomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genomics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic Acids Extraction and QC
Gene Expression Services
Genotyping Services and Pharmacogenomics
Data Analysis and Interpretation
Others
Segmentation by application
Hospitals and Clinics
Pharmaceutical
Research Institutes
Agrochemical
Chemical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
10X Genomics Inc.
Abcam Plc
Agilent Technologies Inc.
Becton Dickinson and Co.
BGI Genomics Co. Ltd.
Bio Rad Laboratories Inc.
Danaher Corp.
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
IQVIA
Beckman Coulter

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Genomics Market Size 2018-2029
      • 2.1.2 Genomics Market Size CAGR by Region 2018 VS 2022 VS 2029
    • 2.2 Genomics Segment by Type
      • 2.2.1 Nucleic Acids Extraction and QC
      • 2.2.2 Gene Expression Services
      • 2.2.3 Genotyping Services and Pharmacogenomics
      • 2.2.4 Data Analysis and Interpretation
      • 2.2.5 Others
    • 2.3 Genomics Market Size by Type
      • 2.3.1 Genomics Market Size CAGR by Type (2018 VS 2022 VS 2029)
      • 2.3.2 Global Genomics Market Size Market Share by Type (2018-2023)
    • 2.4 Genomics Segment by Application
      • 2.4.1 Hospitals and Clinics
      • 2.4.2 Pharmaceutical
      • 2.4.3 Research Institutes
      • 2.4.4 Agrochemical
      • 2.4.5 Chemical
      • 2.4.6 Others
    • 2.5 Genomics Market Size by Application
      • 2.5.1 Genomics Market Size CAGR by Application (2018 VS 2022 VS 2029)
      • 2.5.2 Global Genomics Market Size Market Share by Application (2018-2023)
  • 3 Genomics Market Size by Player

    • 3.1 Genomics Market Size Market Share by Players
      • 3.1.1 Global Genomics Revenue by Players (2018-2023)
      • 3.1.2 Global Genomics Revenue Market Share by Players (2018-2023)
    • 3.2 Global Genomics Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Genomics by Regions

    • 4.1 Genomics Market Size by Regions (2018-2023)
    • 4.2 Americas Genomics Market Size Growth (2018-2023)
    • 4.3 APAC Genomics Market Size Growth (2018-2023)
    • 4.4 Europe Genomics Market Size Growth (2018-2023)
    • 4.5 Middle East & Africa Genomics Market Size Growth (2018-2023)
  • 5 Americas

    • 5.1 Americas Genomics Market Size by Country (2018-2023)
    • 5.2 Americas Genomics Market Size by Type (2018-2023)
    • 5.3 Americas Genomics Market Size by Application (2018-2023)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Genomics Market Size by Region (2018-2023)
    • 6.2 APAC Genomics Market Size by Type (2018-2023)
    • 6.3 APAC Genomics Market Size by Application (2018-2023)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Genomics by Country (2018-2023)
    • 7.2 Europe Genomics Market Size by Type (2018-2023)
    • 7.3 Europe Genomics Market Size by Application (2018-2023)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Genomics by Region (2018-2023)
    • 8.2 Middle East & Africa Genomics Market Size by Type (2018-2023)
    • 8.3 Middle East & Africa Genomics Market Size by Application (2018-2023)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Genomics Market Forecast

    • 10.1 Global Genomics Forecast by Regions (2024-2029)
      • 10.1.1 Global Genomics Forecast by Regions (2024-2029)
      • 10.1.2 Americas Genomics Forecast
      • 10.1.3 APAC Genomics Forecast
      • 10.1.4 Europe Genomics Forecast
      • 10.1.5 Middle East & Africa Genomics Forecast
    • 10.2 Americas Genomics Forecast by Country (2024-2029)
      • 10.2.1 United States Genomics Market Forecast
      • 10.2.2 Canada Genomics Market Forecast
      • 10.2.3 Mexico Genomics Market Forecast
      • 10.2.4 Brazil Genomics Market Forecast
    • 10.3 APAC Genomics Forecast by Region (2024-2029)
      • 10.3.1 China Genomics Market Forecast
      • 10.3.2 Japan Genomics Market Forecast
      • 10.3.3 Korea Genomics Market Forecast
      • 10.3.4 Southeast Asia Genomics Market Forecast
      • 10.3.5 India Genomics Market Forecast
      • 10.3.6 Australia Genomics Market Forecast
    • 10.4 Europe Genomics Forecast by Country (2024-2029)
      • 10.4.1 Germany Genomics Market Forecast
      • 10.4.2 France Genomics Market Forecast
      • 10.4.3 UK Genomics Market Forecast
      • 10.4.4 Italy Genomics Market Forecast
      • 10.4.5 Russia Genomics Market Forecast
    • 10.5 Middle East & Africa Genomics Forecast by Region (2024-2029)
      • 10.5.1 Egypt Genomics Market Forecast
      • 10.5.2 South Africa Genomics Market Forecast
      • 10.5.3 Israel Genomics Market Forecast
      • 10.5.4 Turkey Genomics Market Forecast
      • 10.5.5 GCC Countries Genomics Market Forecast
    • 10.6 Global Genomics Forecast by Type (2024-2029)
    • 10.7 Global Genomics Forecast by Application (2024-2029)
  • 11 Key Players Analysis

    • 11.1 10X Genomics Inc.
      • 11.1.1 10X Genomics Inc. Company Information
      • 11.1.2 10X Genomics Inc. Genomics Product Offered
      • 11.1.3 10X Genomics Inc. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.1.4 10X Genomics Inc. Main Business Overview
      • 11.1.5 10X Genomics Inc. Latest Developments
    • 11.2 Abcam Plc
      • 11.2.1 Abcam Plc Company Information
      • 11.2.2 Abcam Plc Genomics Product Offered
      • 11.2.3 Abcam Plc Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.2.4 Abcam Plc Main Business Overview
      • 11.2.5 Abcam Plc Latest Developments
    • 11.3 Agilent Technologies Inc.
      • 11.3.1 Agilent Technologies Inc. Company Information
      • 11.3.2 Agilent Technologies Inc. Genomics Product Offered
      • 11.3.3 Agilent Technologies Inc. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.3.4 Agilent Technologies Inc. Main Business Overview
      • 11.3.5 Agilent Technologies Inc. Latest Developments
    • 11.4 Becton Dickinson and Co.
      • 11.4.1 Becton Dickinson and Co. Company Information
      • 11.4.2 Becton Dickinson and Co. Genomics Product Offered
      • 11.4.3 Becton Dickinson and Co. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.4.4 Becton Dickinson and Co. Main Business Overview
      • 11.4.5 Becton Dickinson and Co. Latest Developments
    • 11.5 BGI Genomics Co. Ltd.
      • 11.5.1 BGI Genomics Co. Ltd. Company Information
      • 11.5.2 BGI Genomics Co. Ltd. Genomics Product Offered
      • 11.5.3 BGI Genomics Co. Ltd. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.5.4 BGI Genomics Co. Ltd. Main Business Overview
      • 11.5.5 BGI Genomics Co. Ltd. Latest Developments
    • 11.6 Bio Rad Laboratories Inc.
      • 11.6.1 Bio Rad Laboratories Inc. Company Information
      • 11.6.2 Bio Rad Laboratories Inc. Genomics Product Offered
      • 11.6.3 Bio Rad Laboratories Inc. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.6.4 Bio Rad Laboratories Inc. Main Business Overview
      • 11.6.5 Bio Rad Laboratories Inc. Latest Developments
    • 11.7 Danaher Corp.
      • 11.7.1 Danaher Corp. Company Information
      • 11.7.2 Danaher Corp. Genomics Product Offered
      • 11.7.3 Danaher Corp. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.7.4 Danaher Corp. Main Business Overview
      • 11.7.5 Danaher Corp. Latest Developments
    • 11.8 Eppendorf AG
      • 11.8.1 Eppendorf AG Company Information
      • 11.8.2 Eppendorf AG Genomics Product Offered
      • 11.8.3 Eppendorf AG Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.8.4 Eppendorf AG Main Business Overview
      • 11.8.5 Eppendorf AG Latest Developments
    • 11.9 Eurofins Scientific SE
      • 11.9.1 Eurofins Scientific SE Company Information
      • 11.9.2 Eurofins Scientific SE Genomics Product Offered
      • 11.9.3 Eurofins Scientific SE Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.9.4 Eurofins Scientific SE Main Business Overview
      • 11.9.5 Eurofins Scientific SE Latest Developments
    • 11.10 F. Hoffmann-La Roche Ltd.
      • 11.10.1 F. Hoffmann-La Roche Ltd. Company Information
      • 11.10.2 F. Hoffmann-La Roche Ltd. Genomics Product Offered
      • 11.10.3 F. Hoffmann-La Roche Ltd. Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
      • 11.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
    • 11.11 IQVIA
      • 11.11.1 IQVIA Company Information
      • 11.11.2 IQVIA Genomics Product Offered
      • 11.11.3 IQVIA Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.11.4 IQVIA Main Business Overview
      • 11.11.5 IQVIA Latest Developments
    • 11.12 Beckman Coulter
      • 11.12.1 Beckman Coulter Company Information
      • 11.12.2 Beckman Coulter Genomics Product Offered
      • 11.12.3 Beckman Coulter Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.12.4 Beckman Coulter Main Business Overview
      • 11.12.5 Beckman Coulter Latest Developments
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.